Splatter

Palla Pharma Norway

We keep it simple by being transparent, honest and reliable.

We do what we say, and always strive to deliver on time in full.
Person in labcoat

Heading

Lorem ipsum dolor sit amet, conse
tetur sadipscing elitr, sed diam nonu my eirmod tempor diam.

Transparency Act

The purpose of the Transparency Act is to promote companies' respect for fundamental human rights and decent working conditions, and to ensure public access to information. Palla Pharma Norway AS is covered by the law and has implemented measures for compliance with this.

If you have questions regarding the Norwegian Transparency Act. Please contact by email transparencyact@pallapharma.no or through our mailing address Palla Pharma Norway AS,Gruveveien 1, 3770 Kragerø Norway

Transparency Act
pharmaceutical instrument

About

Palla Pharma Norway (PPN),  an independent 100% Norwegian owned pharmaceutical company originally established in 1949 that produces active pharmaceutical ingredients (API) and finished dose formulations (FDF) for a global market.

We see ourselves as a highly adaptable, forward-thinking, and innovative company that has earned a reputation among customers for the high quality of our products and services. Palla Pharma has developed an innovative, efficient, and environmentally - sustainable extraction and purification manufacturing process for API and are highly experienced when it comes to transforming powder into finished dose formulations. We have adopted industry best practices across every facet of our operations from procurement to sales. Palla Pharma Norway’s biggest asset is our experienced and highly skilled employees that provides PPN with its greatest advantage.

Reporting of adverse events

Suspected Adverse Drug Reactions

If you are experiencing any undesirable effects, or you are worried following the use of a products, please first refer to a Health Care Professional such as a doctor or pharmacist, or telephone 111. Take the product with you to any consultation in the original packaging with the leaflet.

Please keep the product in accordance with the conditions specified on the labelling (typically below 25°C) and do not throw anything away until the investigation is complete.

We cannot offer medical advice however please report the details to us after you have received any required medical treatment by telephoning our 24-hour telephone number +386 123 22095 or emailing phv@billeveast.com using the English language.

If you are asked to leave a message someone will response as soon as possible.

Product Information Enquiries

If you have a general enquiry regarding the use of the product, please call +386 123 22095 or emailing phv@billeveast.com. If you are asked to leave a message someone will response as soon as possible.

Complaints

Product quality complaints regarding Codeine Phosphate and tablets produced by Palla Pharma Norway AS

Codeine phopshate hemihydrate
Co-Codamol 30/500mg Tablets (capsule shaped)
Co-Codamol 30/500mg Tablets (round)
Emcozin 30/500mg Tablets
Co-Dydramol 10/500mg Tablets
Uploading...
fileuploaded.jpg
Upload failed. Max size for files is 10 MB.

When you click send, you agree to allow Palla Pharma to store and process your personal information to provide the service and contact you for relevant communication. Please refer to the privacy terms for more information.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Contact

When you click send, you agree to allow Palla Pharma to store and process your personal information to provide the service and contact you for relevant communication. Please refer to the privacy terms for more information.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.